SCHEMBL8428336

SCHEMBL8428336

CCC1=C(Cc2nnn[nH]2)c2c3cccc2C(c2ccc(Cl)cc2)=C13

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
GCGR P47871 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8428466 0.82 MAPT (0.36)
SCHEMBL8430715 0.74 IKBKB (0.32)
SCHEMBL8430781 0.73 IKBKB (0.33)
SCHEMBL8428338 0.72 RXRA (0.36)
SCHEMBL8428611 0.72
SCHEMBL8428371 0.71 MAPT (0.39)
SCHEMBL6505678 0.67 NR1H2 (0.41)
SCHEMBL8432130 0.64 PDE4B (0.37)
SCHEMBL7684407 0.62 TAAR1 (0.50)
SCHEMBL8430246 0.62 MAP2 (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5965619-A ADMINISTERING AN INDENE DERIVATIVE OF GIVEN FORMULA, SUCH AS 1-(2,4,6-TRIMETHOXYBENZYLIDENE)-5-DIMETHYLAMINO-2-METHYL-3-INDENYL ACETIC ACID, TO TREAT PRECANCEROUS LESIONS SUCH AS COLONIC ADENOMATOUS POLYPS; SIDE EFFECT REDUCTION CELL PATHWAYS INC. (US) 1999-10-12 US disclosed